FARLETUZUMAB
UNII 2O09BG0OWA

Substance Identification & Data

This profile provides standardized clinical and technical data for Farletuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2O09BG0OWA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 896723-44-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2O09BG0OWA

CAS Registry Number

896723-44-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FARLETUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C61503

National Cancer Institute reference terminology for clinical and research data.

INN ID

9067

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

TT-118

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Farletuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FARLETUZUMAB

Common Names & Synonyms

FARLETUZUMAB [INN]

FARLETUZUMAB [JAN]

FARLETUZUMAB [MART.]

FARLETUZUMAB [USAN]

FARLETUZUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER

Technical Codes

MORAB-003

External Clinical & Regulatory Resources

Previous UNII2O051W13LH

Next UNII2O0DP12TG4